FilingSEC EDGARF-1/A
Polyrizon Completes $4 Million Offering and Clinical Site Network
· SEC accepted
StageOffering Closed and Clinical Preparation
Filing content
Polyrizon completed a $4 million registered direct offering on September 3 and finalized its clinical site network for the NASARIXTM study.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…